Last reviewed · How we verify
Feasibility Study of the Tendyne Mitral Valve System in Mitral Annular Calcification
This study is a prospective, single-arm, multi-center feasibility clinical study of the Tendyne Mitral Valve System for the treatment of eligible subjects with symptomatic, severe mitral regurgitation and severe mitral annular calcification (MAC). Subjects satisfying the study inclusion/exclusion criteria will undergo a procedure to implant the Tendyne mitral valve replacement device.
Details
| Lead sponsor | Abbott Medical Devices |
|---|---|
| Phase | NA |
| Status | COMPLETED |
| Enrolment | 11 |
| Start date | Wed Oct 10 2018 00:00:00 GMT+0000 (Coordinated Universal Time) |
| Completion | Tue Jun 18 2024 00:00:00 GMT+0000 (Coordinated Universal Time) |
Conditions
- Mitral Regurgitation
- Mitral Insufficiency
- Mitral Annular Calcification
- Mitral Annulus Calcification
- Cardiovascular Diseases
- Valve Heart Disease
- Heart Valve Diseases
- Heart Valve Calcification
- Mitral Valve Disease
Interventions
- Tendyne Mitral Valve System
Countries
United States